In this study, we genetically overexpressed Wnt5a in MSCs for the first time and demonstrated that MSCWnt5a enhances the therapeutic potential of MSCs on endothelial injury, thereby optimizing the use of MSCs in ALI/ARDS. The gene discussed is WNT5A; the disease is acute respiratory distress syndrome.